A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension

PHASE3TerminatedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

December 10, 2018

Primary Completion Date

July 20, 2019

Study Completion Date

July 20, 2019

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Esuberaprost

Sodium tablets

DRUG

Placebo

Placebo tablets, which are identical in size and appearance to those containing Esuberaprost.

Trial Locations (45)

10029

The Mount Sinai Hospital, New York

12208

Albany Medical Center, Albany

15213

University of Pittsburgh Medical Center, Pittsburgh

19107

Thomas Jefferson University, Philadelphia

21201

University of Maryland Medical Center, Baltimore

21205

Johns Hopkins University, Baltimore

23507

Sentara Cardiovascular Research Institute, Norfolk

27599

University of North Carolina at Chapel Hill, Chapel Hill

27710

Duke University Medical Center, Durham

29621

Anderson Pharmaceutical Research, LLC, Anderson

30106

Georgia Clinical Research, Austell

30322

Emory University, Atlanta

30342

Pulmonary & Critical Care of Atlanta, Atlanta

32610

University of Florida Clinical Research Center, Gainesville

32803

Florida Hospital, Orlando

33143

South Miami Heart Specialists, South Miami

33331

Cleveland Clinic Florida, Weston

33511

Bay Area Cardiology Research, Brandon

35294

The University of Alabama at Birmingham, Birmingham

40202

University of Louisville Research Foundation, Louisville

43221

The Ohio State University Wexner Medical Center, Columbus

43614

The University of Toledo, Toledo

46202

Indiana University Health North Hospital, Indianapolis

48085

Beaumont Health, Troy

49100

Rabin Medical Center, Petah Tikva

52621

The Chaim Sheba Medical Center, Tel Litwinsky

54224

University of Iowa Hospitals and Clinics, Iowa City

70121

Ochsner Clinic Foundation, New Orleans

75390

UT Southwestern Medical Center, Dallas

76508

Scott & White Memorial Hospital, Temple

80045

University of Colorado Health Sciences Center, Aurora

80120

South Denver Cardiology Associates, Littleton

80128

Aurora Denver Cardiology Associates, Denver

90024

University of California Los Angeles UCLA, Los Angeles

90073

West Los Angeles VA Healthcare Center, Los Angeles

90211

Cedars-Sinai Medical Center, Beverly Hills

90502

Harbor-UCLA Medical Center, Torrance

92093

University of California San Diego Medical Center, La Jolla

92683

Allianz Research Institute, Westminster

93102

Santa Barbara Pulmonary Associates, Santa Barbara

94305

Stanford Hospital and Clinics, Stanford

97239

Oregon Health and Science University, Portland

98195

University of Washington Medical Center, Seattle

02115

Brigham and Women's Hospital, Boston

02903

Rhode Island Hospital, Providence

Sponsors
All Listed Sponsors
lead

Lung Biotechnology PBC

INDUSTRY

NCT03657095 - A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter